Paul Ockelford

4.7k total citations · 2 hit papers
63 papers, 3.5k citations indexed

About

Paul Ockelford is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul Ockelford has authored 63 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 22 papers in Internal Medicine and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul Ockelford's work include Venous Thromboembolism Diagnosis and Management (22 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Hemophilia Treatment and Research (13 papers). Paul Ockelford is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (22 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers) and Hemophilia Treatment and Research (13 papers). Paul Ockelford collaborates with scholars based in New Zealand, Australia and Canada. Paul Ockelford's co-authors include J. Hirsh, Alexander Gallus, Michael Gent, Richard M. Jay, Harry R. Büller, Pascal d’Azemar, Jan van der Meer, A.G.M. van den Belt, Patrick M. Bossuyt and Franco Piovella and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Paul Ockelford

60 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home

1996 810 citations Maria M.W. Koopman, Paolo Prandoni et al. New England Journal of Medicine profile →
Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein Thrombosis

1982 560 citations J. Hirsh, Paul Ockelford et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Ockelford New Zealand	22	2.3k	1.9k	1.0k	928	340	63	3.5k
Rainer B. Zotz Germany	24	1.5k 0.6×	1.5k 0.8×	626 0.6×	1.1k 1.2×	215 0.6×	78	3.3k
Timothy Brighton Australia	23	2.2k 0.9×	1.8k 1.0×	732 0.7×	1.1k 1.2×	183 0.5×	58	3.4k
A. K. Kakkar United Kingdom	21	2.0k 0.9×	1.4k 0.8×	600 0.6×	573 0.6×	322 0.9×	46	2.7k
Ismaı̈l Elalamy France	32	1.8k 0.8×	1.3k 0.7×	884 0.9×	1.2k 1.3×	263 0.8×	241	4.9k
Patrick Mismetti France	33	2.9k 1.2×	2.2k 1.2×	1.0k 1.0×	628 0.7×	843 2.5×	154	4.2k
Grigoris Gerotziafas France	30	1.7k 0.7×	1.2k 0.6×	799 0.8×	1.1k 1.2×	208 0.6×	163	4.3k
Alejandro Lazo‐Langner Canada	29	1.6k 0.7×	1.0k 0.6×	588 0.6×	696 0.8×	372 1.1×	169	3.2k
Alexander G.G. Turpie Canada	18	2.8k 1.2×	2.7k 1.5×	889 0.9×	600 0.6×	483 1.4×	48	3.7k
Theodore E. Spiro United States	29	2.5k 1.1×	2.3k 1.3×	879 0.9×	319 0.3×	218 0.6×	66	3.4k
Hans Johnsson Sweden	27	1.4k 0.6×	1.3k 0.7×	452 0.4×	933 1.0×	141 0.4×	96	2.8k

Countries citing papers authored by Paul Ockelford

Since Specialization

Citations

This map shows the geographic impact of Paul Ockelford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Ockelford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Ockelford more than expected).

Fields of papers citing papers by Paul Ockelford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Ockelford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Ockelford. The network helps show where Paul Ockelford may publish in the future.

Co-authorship network of co-authors of Paul Ockelford

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Ockelford. A scholar is included among the top collaborators of Paul Ockelford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Ockelford. Paul Ockelford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Merriman, Eileen, Sanjeev Chunilal, Tim Brighton, et al.. (2021). Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study). Thrombosis Research. 207. 33–39. 4 indexed citations

Brown, Simon, J. Phillips, Chris Barnes, et al.. (2015). Challenges in hemophilia care in Australia and New Zealand. Current Medical Research and Opinion. 31(11). 1985–1991. 6 indexed citations

Brighton, Timothy, John W. Eikelboom, K. Mann, et al.. (2012). Low-Dose Aspirin for Preventing Recurrent Venous Thromboembolism. New England Journal of Medicine. 367(21). 1979–1987. 386 indexed citations

Prestidge, Tim, Shane Lee, Pauline Harper, Laura Young, & Paul Ockelford. (2010). Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location. Internal Medicine Journal. 42(1). 71–74. 10 indexed citations

Ashton, Fern, et al.. (2004). Mutations within the protein Z‐dependent protease inhibitor gene are associated with venous thromboembolic disease: a new form of thrombophilia. British Journal of Haematology. 127(2). 190–194. 40 indexed citations

Young, Laura, Paul Ockelford, & Pauline Harper. (2004). Audit of community‐based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary?. Internal Medicine Journal. 34(11). 639–641. 11 indexed citations

Ockelford, Paul, et al.. (2000). Hydroxyurea induced skin ulceration in myeloproliferative disorders. Australian and New Zealand Journal of Medicine. 30(3). 373–376. 2 indexed citations

Ockelford, Paul, et al.. (1999). Screening for a prothrombotic diathesis in patients attending family planning clinics.. PubMed. 112(1096). 358–61. 10 indexed citations

Ockelford, Paul, et al.. (1998). A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertion.. PubMed. 79(5). 938–42. 48 indexed citations

10.

McPherson, Jean, Lochie Teague, J. V. Lloyd, et al.. (1996). Experience with Recombinant Factor VIla in Australia and New Zealand. Pathophysiology of Haemostasis and Thrombosis. 26(Suppl. 1). 109–117. 16 indexed citations

11.

Koopman, Maria M.W., Paolo Prandoni, Franco Piovella, et al.. (1996). Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home. New England Journal of Medicine. 334(11). 682–687. 810 indexed citations breakdown →

12.

Gallus, Alexander, J. F. Cade, Paul Ockelford, et al.. (1993). Orgaran (Org 10172) or Heparin for Preventing Venous Thrombosis after Elective Surgery for Malignant Disease? A Double-Blind, Randomised, Multicentre Comparison. Thrombosis and Haemostasis. 70(4). 562–567. 45 indexed citations

13.

Fay, Keith, Stephen O. Brennan, Howard Potter, et al.. (1993). Haemoglobin Manukau β67[E11] Val→Gly: transfusion‐dependent haemolytic anaemia ameliorated by coexisting alpha thalassaemia. British Journal of Haematology. 85(2). 352–355. 9 indexed citations

14.

Fletcher, John, Jerry Koutts, & Paul Ockelford. (1992). DEEP VEIN THROMBOSIS PROPHYLAXIS: A SURVEY OF CURRENT PRACTICE IN AUSTRALIA AND NEW ZEALAND. Australian and New Zealand Journal of Surgery. 62(8). 601–605. 19 indexed citations

15.

Royle, Gordon, et al.. (1991). Haemophilia B Leyden arising de novo by point mutation in the putative factor IX promoter region. British Journal of Haematology. 77(2). 191–194. 20 indexed citations

16.

Ockelford, Paul, et al.. (1988). Comparative separation of human plasma proteins on polysulphated chromatographic media. Thrombosis Research. 49(2). 277–286. 2 indexed citations

17.

Ockelford, Paul, et al.. (1987). Controlled pore glass factor VIII concentrate: Influence of heat treatment. Pathology. 19(1). 56–57. 3 indexed citations

18.

Ockelford, Paul, et al.. (1985). In vivo activity of a new heparinoid. Pathology. 17(1). 78–81. 7 indexed citations

19.

Henny, Ch. P., H van Bronswijk, Hugo Ten Cate, et al.. (1983). USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONS. The Lancet. 321(8330). 890–893. 47 indexed citations

20.

Blacklock, Hilary, et al.. (1981). Improved survival from acute lymphoblastic leukemia in adolescents and adults. Cancer. 48(9). 1931–1935. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact